Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies
Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this project is to assess the efficacy of loratadine in decreasing the
incidence and severity of bone pain following G-CSF administration in patients with
hematologic malignancies, patients undergoing mobilization of hematopoietic progenitor cells,
and patients who have undergone an autologous hematopoietic cell transplant. This is a
different patient population than those being assessed in current clinical trials.